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Abstract
Pharmacologically active molecules can provide remedies for a range of different illnesses
and infections. Therefore, the search for such bioactive molecules has been an enduring
mission. As such, there is a need to employ a more suitable, reliable, and robust classifica-
tion method for enhancing the prediction of the existence of new bioactive molecules. In this
paper, we adopt a recently developed combination of different boosting methods (Adaboost)
for the prediction of new bioactive molecules. We conducted the research experiments utiliz-
ing the widely used MDL Drug Data Report (MDDR) database. The proposed boosting
method generated better results than other machine learning methods. This finding sug-
gests that the method is suitable for inclusion among the in silico tools for use in cheminfor-
matics, computational chemistry and molecular biology.
Background
Virtual screening, which has its roots in cheminformatics, computational chemistry and struc-
tural biology [1], is the computation of the similarity between the target (reference structure)
and each molecule in a database [2]. It is an established method for the discovery of new bio-
logically active molecules [3]. It is a process whereby, through molecular modeling, each chem-
ical agent in a database is docked into the binding region of each macro molecule target [4].
Docking is the process whereby the best fit for each agent in the binding region of the macro-
molecular target is calculated [4]. Schneider and Bohm [5] provided a survey of fast automated
docking methods, and a detailed study on the calculation of an optimal box size for molecular
docking against predicted binding pockets was carried out by Feinstein and Brylinski [6].
Wang et al. [7] extensively reviewed grapheme-based glucose sensors spanning from the
period of 2008 to 2015. Huang et al. [8] worked on Drosophila, where Piwi-piRNA was the
guiding epigenetic mechanism to target sites. Their work provided insight into the process
involved in the recruitment of epigenetic factors to their target sites. Meanwhile, Marinov et al.
[9] investigated the work of Huang et al. and discovered that their genome-wide result was not
supported by their dataset. The work of Lin et al. [10] confirmed Marinov et al. who stated that
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the genomic site was not discovered and reaffirmed that the genome RNA polymerase II distri-
bution is influenced by Piwi. Watanabe and Lin reviewed piRNA with respect to some biologi-
cal processes, and their detailed work can be found in [11]. The science of processing bioactive
molecules in important fields, such as lead discovery and compound optimization, has evolved
in recent years [12]. The literature has extensively discussed different virtual screening tech-
niques [13–16] and activity prediction approaches [17].
For example, Burden and Winkler [18] introduced the Quantitative Structure-Activity
Relationship (QSAR) method as a solution to large datasets and then proposed back propaga-
tion (BP) after comparing this method with Multiple Linear Regression (MLR), Principal
Component Regression (PCR) and Partial Least Squares (PLS) methods. They applied QSAR
to massive data sets derived from combinatorial chemistry and High Throughput Screening
(HTS). QSAR involves the prediction of the biological activity of a compound from a vectoral
representation of molecular structure [19]. QSAR has been successfully utilized with regards to
many drugs and agro-chemical design problems. In Burden and Winkler’s study [18], more
information concerning the challenges of QSAR was outlined, and Rogers and Hopfinger [20]
solved the problem of building QSAR and Quantity Structure-Property Relationship (QSPR)
models using Genetic Function Approximation (GFA). In their work, they disclosed that the
secret of the GFA lies in the creation and use of multiple models, rather than the utilization of
a single method. Additionally, the unclear QSAR between plant-derived flavones and their
inhibiting effects on aurora B kinase (aurB) was established [21].
In the relevant literature, several similarity search methods have been proposed [22]. Sheri-
dan and Kearsley [22] justified the need for many chemical similarity search methods in the
early discovery of leads in a drug discovery project. Detailed reviews of chemical similarity
searching and virtual screening can be found in Shneider and Bohm [5] and Willett, Barnard
and Downs [23].
In this modern era of computational technological advancement, the adoption of machine
learning algorithms for the prediction of molecules has been explored. Willet et al. [24] applied
the Binary Kernel Discrimination (BKD) approach for the determination of ion channel activ-
ity. BKD was introduced and compared with merged similarity search by Harper [25]. Liu et al.
[26] developed a model based on the Support Vector Machine, which can be used to automati-
cally produce predictors. This model has a four-in-one function of extracting features, selecting
parameters, training models, and cross-validation. This model improves the prediction rate.
A recent survey on the success (to date) and possible opportunities with regards to ligand-
based virtual screening in machine learning was performed by Lavecchia [27]. The successes
include the development of a large-scale machine learning data protocol, in the work of
George et al. [28]; machine learning algorithms in multidimensional analysis of classification
performance of compounds, Kurczab and Bojarski [29]; the Naive Bayesian classifier, Kurczab,
Smusz and Bojarski [15], Bender et al. [30], and Glick et al. [31]; the Bayesian belief network,
Abdo et al. [17], Nidhi et al. [32], and Xia et al. [33]; Support vector machines, Bruce et al. [19]
and Buchwald, Ritter and Kramer [34]; Binary kernel discrimination, Willett et al. [24] and
Reynolds and Sternberg [25]; the C5 (decision tree), Cao et al. [35]; and Investigational Novel
Drug Discovery by Example (INDDEXTM), Reynolds and Sterberg [16].
Krasowski and Ekins [36] addressed the challenges faced in correctly detecting and identi-
fying a molecule intake into a class. They utilized cheminformatics to determine the cross reac-
tivity of designer drugs to their available immunoassay (procedure for detecting or measuring
specific proteins or other substances through their properties as antigens) [36].
Stumpfe and Bajorath’s study [37] focuses on the practical applications, calculation, and
appropriate domain of ligand-based virtual screening. Sherhod et al. [38] generated structural
fragmented descriptors by applying a contrast pattern tree mining algorithm. The pattern
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forms hierarchical clusters of compounds that represent different classes of chemicals. This
method was able to identify common toxic features and their classes. Takigawa and Mamit-
suka [39] further elaborated on this idea and the procedures for mining frequent sub-graphs
for compounds with molecular graphs and chemical compounds.
Smusz et al. [40] adapted virtual screening for their work on the discovery of two structur-
ally new 5-HT6R ligands, and Me´tivier et al. [41] worked on the discovery of structural alerts.
In recent research, clustering algorithms have also been used in cheminformatics to discover
drugs. A detailed study [42] compares popular clustering techniques, namely, k-means, bisect-
ing k-means and ward clustering. The applications of clustering include QSAR analysis, High
Throughput Screening (HTS), and Absorption, Distribution, Metabolism, Elimination and
Toxicity (ADMET) prediction [42]. Meanwhile, Pires et al. [43] proposed a novel technique,
called pkCSM, to develop predictive models for toxicity properties and small-molecule phar-
macokinetics using graph-based signatures [43].
Ensembles have proven to be suitable in improving the performance of a prediction model
since they utilize the ability of more than one classifier. They have been used to identify DNA-
binding proteins [44] and Piwi-Interacting RNAs [45].
The purpose of our research is to enhance the prediction of bioactive molecules using the
boosting algorithm ensemble AdaboostM1 in conjunction with Bagging, Jrip, PART, Random
Forest, REPTree and J48 as nominal classifiers. We also compared the performances of the
boosting algorithm with a support vector machine classifier called LibSVM (LSVM) [17, 46].
Materials and methods
Data sets
Bioactive molecules from both natural products and synthetic compounds are precious
sources that provide us with the necessary tools to create new drugs to cure diseases [17].
Molecular fingerprints are representations of chemical structures initially designed to support
chemical database substructure searching. Subsequently, their use had been for analysis tasks,
such as similarity searching, clustering, and classification. extended connectivity fingerprints
(ECFPs) is a recently developed fingerprint methodology specifically designed to identify
molecular features significant to molecular activity [47].
Three datasets from ECFP_4 standard molecular descriptors, which were used in previous
studies, were used for this study. These datasets were retrieved from the MDDR database. The
datasets consist of 8294, 5083, and 8568 instances for DS1, DS2, and DS3, respectively, as
shown in Tables 1–3. The quality of prediction was based on these datasets and the validation
of the classification of molecules was based on the structure-activity relationship.
The three datasets were pre-processed on the work bench via the following filters: unsuper-
vised, attributes, and Numeric to Nominal. DS 1 contains eleven normal activity classes, DS2 con-
tains ten homogenous (average) activity classes, and DS 2 contains ten heterogeneous activity
classes. Tables 1–3 show activity index, activity class, active molecules and pairwise similarity
(mean). The active molecules are the number of molecules or peptides belonging to the class and
the diversity of classes. The diversity of the class is computed as the mean pairwise Tanimoto simi-
larity score calculated across all pairs of molecules/peptides in the class using ECFP_4.
Ensemble learning technique
The employment of AdaboostM1 has been discussed in the literature, see for instance [48, 1].
It is a boosting machine learning algorithm [49] that works with another classifier (called the
nominal classifier). It works successfully when the nominal classifier in question (also referred
to as weak learner) can achieve at least 50% accuracy on its own [49].
Ensemble learning method for prediction of new bioactive molecules
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AdaboostM1 is an ensemble learning technique and the most well-known of the boosting
family of algorithms. The algorithm sequentially trains models, with a new model trained at
each round. At the end of each round, misclassified examples are identified and their emphasis
is increased in a new training set, which is then fed into the next round and processed to train
a new model [50]. The Waikato Environment for Knowledge Analysis (WEKA) software,
Table 1. Activity class for dataset DS1.
Activity Index Activity Class Activity Molecules Pairwise Similarity (Mean)
31420 Renin inhibitors 1130 0.573
71523 HIV protease inhibitors 750 0.446
37110 Thrombin inhibitors 803 0.419
31432 Angiotensin II AT1 antagonists 943 0.403
42731 Substance P antagonists 1246 0.339
06233 5HT3 antagonists 752 0.351
06245 5HT reuptake inhibitors 359 0.345
07701 D2 antagonists 395 0.345
06235 5HT1A agonists 827 0.343
78374 Protein kinase C inhibitors 453 0.323
78331 Cyclooxygenase inhibitors 636 0.268
https://doi.org/10.1371/journal.pone.0189538.t001
Table 3. Activity class for dataset DS3.
Activity Index Activity Class Activity Molecules Pairwise Similarity (Mean)
09249 Muscarinic (M1) agonists 900 0.257
12455 NMDA receptor antagonists 1400 0.311
12464 Nitric oxide synthase inhibitors 505 0.237
31281 Dopamine β-hydroxylase inhibitors 106 0.324
43210 Aldose reductase inhibitors 957 0.37
71522 Reverse transcriptase inhibitors 700 0.311
75721 Aromatase inhibitors 636 0.318
78331 Cyclooxygenase inhibitors 636 0.382
78348 Phospholipase A2 inhibitors 617 0.291
78351 Lipoxygenase inhibitors 2111 0.365
https://doi.org/10.1371/journal.pone.0189538.t003
Table 2. Activity class for dataset DS2.
Activity Index Activity Class Activity Molecules Pairwise Similarity (Mean)
07707 Adenosine (A1) agonists 207 0.424
07708 Adenosine (A2) agonists 156 0.484
31420 Renin inhibitors 1130 0.584
42710 Monocyclic β-lactams 111 0.596
64100 Cephalosporins 1301 0.512
64200 Carbacephems 158 0.503
64220 Carbapenems 1051 0.414
64300 Penicillin 126 0.444
65000 Antibiotic, macrolide 388 0.673
75755 Vitamin D analogous 455 0.569
https://doi.org/10.1371/journal.pone.0189538.t002
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which is cross-platform software with various machine learning algorithms written in Java,
was used to carry out the study. AdaboostM1 is shown in Algorithm 1 (below).
Algorithm 1: AdaboostM1
Input
Sequence of m examples < (x1,ym),. . .,(xm,ym) > with labels yi 2 Y =
{1,. . .,k}
weak learning algorithm weakLearn
integer T specifying number of iterations
Initialize D1ðiÞ ¼ 1m for all i.
Do for t = 1, 2,. . .xo, T
1. Call weakLearn, providing it with the distribution Dt.
2. Get back a hypothesis ht: X ! Y.
3. Calculate the error of ht: 2 t ¼
P
i:hiðxiÞ6¼yi
DtðiÞ. If 2 t > 12, then set
T = t– 1 and abort loop.
4. Set βt = 2 t/ (1−2 t).
5. Update distribution Dt : Dtþ1ðiÞ ¼
Dt ðiÞ
Zt

βt
ifhtðxiÞ¼yi
1otherwise
(
where Zt is a normalisation constant (chosen so that Dt+1 will be a
distribution).
Output
The final hypothesis: hfin xð Þ ¼ arg maxy2Y
P
t:ht ðxÞ¼y
log 1
bt
Experimental design
The need to have a known drug that is classifiable to a specific biological molecular structure is
a central part of computational chemistry [51]. In this experiment, we used the extended-con-
nectivity fingerprints (ECFP4) developed by SciTegic [32]. The ECFP4 of MDDR (MDL Drug
Data Report) [52] implementation in the test cases is used in this study.
Discovering the optimal parameters for a classifier was a time-consuming task. WEKA-
Workbench offers the possibility of automatically finding the best possible setup for the
LSVM classifier. The values of 1.0, 0.1, and 0.001 were given to the Cost, Gamma and Epsilon
parameters, respectively, while the default values available in WEKA-Workbench were used
for the other parameters. In this study, six AdaBoost ensemble classifiers were applied, includ-
ing AdaBoostM1+Bagging (Ada_Bag), AdaBoostM1+Jrip (Ada_Jrip), AdaBoostM1+J48
(Ada_J48), AdaBoostM1+PART (Ada_PART), AdaBoostM1+RandomForest (Ada_RF), and
AdaBoostM1+REPTree (Ada_RT). Subsequently, a ten-fold cross-validation was carried out,
and the results were evaluated using sensitivity, specificity, and area under the curve (AUC)
measurements.
All experiments were conducted using a personal computer with an Intel1 Core ™ i7-4790
CPU 3.60 GHz processor, with 16 GB RAM, and a 64-bit operating system. There are some
required settings in the configuration of WEKA to increase the heap size of the memory in the
“RunWeka.ini” file under the parameter named “maxheap” with the value of “4096M”. This
action supports the processing of the large amount of MDDR datasets being used (the original
value was “1024M”).
To validate the performance of each classifier, we used the confusion matrix of the classifi-
cation results as a measure to compute all the evaluation parameters. The percentage of cor-
rectly classified instances from the 10-fold cross validation was used as the measure for the
model. In cross validation, the parameter value of 10 was used as the default value. This result
suggests that the data set is divided into 10 folds; one fold was used for testing, and the rest
were used for training. This process was repeated 10 times so that all folds were used as a test
fold once. The error rate is calculated by computing the average of the 10-fold errors.
Ensemble learning method for prediction of new bioactive molecules
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The area under the receiver operating characteristic curve (AUC), specificity, sensitivity
and accuracy were used as the machine learning evaluation methods. These methods are
widely used as quality criteria to quantify performance. They are defined as follow:
Sensitivity ¼
TP
TPþ FN
Specificity ¼
TN
TN þ FP
Accuracy ¼
ðTPþ TNÞ
ðTPþ TN þ FPþ FNÞ
Where TP = True Positive, FN = False Negative, TN = True Negative, and FP = False Positive.
Results and discussion
Tables 4–6 display the sensitivity measures (the true positive rates). A number of the AdaBoost
ensemble classifiers exhibited the best performance and outperformed the existing best classi-
fier in the discovery of novel drugs where 2 (Ada_Bag and Ada_RF) out of 6 AdaBoost classifi-
ers (Table 4 –DS 1) outperformed the existing best classifier (LSVM).
Table 5 (with DS2) shows that 3 (Ada_Bag, Ada_J48, and Ada_RT) out of 6 AdaBoost clas-
sifiers surpassed the LSVM classifier. However, Table 6 (with DS3) illustrates that only 1
(Ada_Bag) out of 6 AdaBoost classifiers surpassed the LSVM classifier.
Tables 7–9 show the specificity measures (the true negative rates), which also demonstrate
that a number of AdaBoost classifiers offered the best performance and surpassed the existing
best classifier in the discovery of novel drugs, where 2 (Ada_Bag and Ada_RF) out of 6 Ada-
Boost classifiers (Table 7 –DS1) outperformed the existing best classifier (LSVM).
Moreover, Table 8 (with DS2) illustrates that 5 (Ada_Bag, Ada_J48, Ada_PART, Ada_RF
and Ada_RT) out of 6 AdaBoost classifiers outperformed the LSVM classifier. Table 9 (with
DS3) illustrates that only 1 (Ada_Bag) out of 6 AdaBoost classifiers surpassed the LSVM classi-
fier in these specificity measures.
Tables 10–12 display the AUC measures, which also shows that a number of the AdaBoost
classifiers offered the best performance and surpassed the existing best classifier in the
Table 4. Sensitivity measure for the prediction of new bioactive molecules with DS1 (normal sataset).
Class
of DS1
Activity Index LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
1 31420 0.978 0.983 0.979 0.980 0.978 0.985 0.977
2 71523 0.933 0.953 0.953 0.945 0.941 0.951 0.953
3 37110 0.980 0.981 0.978 0.978 0.980 0.976 0.971
4 31432 0.990 0.995 0.990 0.986 0.992 0.996 0.989
5 42731 0.986 0.980 0.970 0.970 0.971 0.990 0.968
6 6233 0.973 0.979 0.964 0.961 0.951 0.983 0.969
7 6245 0.905 0.916 0.872 0.855 0.861 0.905 0.886
8 7701 0.851 0.873 0.830 0.823 0.810 0.843 0.813
9 6235 0.941 0.949 0.935 0.906 0.900 0.953 0.933
10 78374 0.945 0.943 0.960 0.932 0.943 0.951 0.916
11 78331 0.970 0.973 0.973 0.947 0.951 0.980 0.961
Mean 0.950 0.957 0.946 0.935 0.934 0.956 0.940
https://doi.org/10.1371/journal.pone.0189538.t004
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Table 6. Sensitivity measure for the prediction of new bioactive molecules with DS3 (heterogeneous).
Class
of DS3
Activity
Index
LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
1 09249 0.980 0.972 0.979 0.970 0.968 0.982 0.974
2 12455 0.955 0.966 0.942 0.942 0.946 0.966 0.949
3 12464 0.909 0.899 0.911 0.907 0.911 0.909 0.893
4 31281 0.972 0.953 0.934 0.868 0.887 0.915 0.896
5 43210 0.950 0.956 0.934 0.947 0.943 0.956 0.937
6 71522 0.914 0.919 0.916 0.913 0.897 0.909 0.880
7 75721 0.980 0.976 0.961 0.945 0.951 0.970 0.956
8 78331 0.838 0.857 0.796 0.808 0.832 0.841 0.838
9 78348 0.898 0.912 0.878 0.901 0.890 0.891 0.867
10 78351 0.943 0.962 0.958 0.942 0.945 0.971 0.949
Mean 0.934 0.937 0.921 0.914 0.917 0.931 0.914
https://doi.org/10.1371/journal.pone.0189538.t006
Table 5. Sensitivity measure for the prediction of new bioactive molecules with DS2 (homogeneous).
Class of DS2 Activity Index LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
1 07707 0.966 0.961 0.966 0.956 0.956 0.971 0.966
2 07708 0.968 0.968 0.962 0.974 0.949 0.987 0.949
3 31420 0.995 0.993 0.995 0.992 0.996 0.996 0.996
4 42710 0.982 0.973 0.973 0.982 0.973 0.964 0.991
5 64100 0.972 0.978 0.981 0.977 0.975 0.982 0.977
6 64200 0.734 0.772 0.715 0.810 0.759 0.722 0.759
7 64220 0.997 0.996 0.993 0.995 0.995 0.995 0.996
8 64300 0.968 0.952 0.952 0.976 0.968 0.968 0.976
9 65000 0.997 0.997 0.997 0.995 0.995 0.995 0.997
10 75755 0.996 0.996 0.993 0.996 0.996 0.996 0.993
Mean 0.958 0.959 0.953 0.965 0.956 0.958 0.960
https://doi.org/10.1371/journal.pone.0189538.t005
Table 7. Specificity measure for the prediction of new bioactive molecules with DS1 (normal dataset).
Class
of DS1
Activity Index LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
1 31420 0.995 0.997 0.997 0.996 0.978 0.996 0.997
2 71523 0.997 0.997 0.997 0.997 0.941 0.998 0.996
3 37110 0.998 0.998 0.998 0.996 0.980 0.998 0.997
4 31432 0.999 0.999 0.999 0.998 0.992 0.998 0.999
5 42731 0.995 0.996 0.994 0.992 0.971 0.995 0.993
6 6233 0.998 0.997 0.997 0.994 0.951 0.997 0.994
7 6245 0.996 0.997 0.997 0.996 0.861 0.997 0.995
8 7701 0.994 0.996 0.993 0.993 0.810 0.997 0.995
9 6235 0.991 0.993 0.988 0.990 0.900 0.991 0.990
10 78374 0.998 0.998 0.998 0.997 0.943 0.999 0.997
11 78331 0.997 0.996 0.997 0.994 0.951 0.997 0.995
Mean 0.996 0.997 0.996 0.995 0.934 0.997 0.995
https://doi.org/10.1371/journal.pone.0189538.t007
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Table 8. Specificity measure for the prediction of new bioactive molecules with DS2 (homogeneous).
Class
of DS2
Activity
Index
LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
1 07707 0.999 0.999 0.999 0.999 0.999 0.999 0.999
2 07708 0.999 0.998 0.999 0.999 0.998 0.998 0.998
3 31420 0.997 0.998 0.998 0.997 0.997 0.998 0.998
4 42710 1.000 0.999 0.999 0.999 0.999 0.999 0.999
5 64100 0.989 0.990 0.987 0.992 0.990 0.989 0.990
6 64200 0.993 0.995 0.995 0.995 0.994 0.996 0.995
7 64220 0.998 0.999 0.999 0.998 0.999 0.998 0.999
8 64300 0.999 1.000 0.999 1.000 1.000 0.999 1.000
9 65000 1.000 0.999 0.999 0.999 0.999 1.000 1.000
10 75755 1.000 1.000 1.000 0.999 1.000 1.000 1.000
Mean 0.997 0.998 0.997 0.998 0.998 0.998 0.998
https://doi.org/10.1371/journal.pone.0189538.t008
Table 9. Specificity measure for the prediction of new bioactive molecules with DS3 (heterogeneous).
Class
of DS3
Activity
Index
LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
1 09249 0.997 0.996 0.996 0.995 0.996 0.996 0.994
2 12455 0.991 0.989 0.992 0.987 0.988 0.989 0.985
3 12464 0.996 0.998 0.996 0.995 0.994 0.999 0.996
4 31281 0.999 1.000 0.999 0.999 0.999 1.000 1.000
5 43210 0.995 0.997 0.996 0.995 0.994 0.996 0.994
6 71522 0.993 0.997 0.998 0.994 0.994 0.999 0.995
7 75721 0.997 0.998 0.997 0.996 0.996 0.998 0.997
8 78331 0.990 0.993 0.991 0.989 0.989 0.996 0.989
9 78348 0.992 0.995 0.995 0.994 0.992 0.996 0.993
10 78351 0.976 0.974 0.956 0.971 0.974 0.965 0.971
Mean 0.993 0.994 0.992 0.992 0.992 0.993 0.991
https://doi.org/10.1371/journal.pone.0189538.t009
Table 10. AUC measure for the prediction of new bioactive molecules with DS1 (normal dataset).
Class
of DS1
Activity Index LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
1 31420 0.987 0.990 0.988 0.988 0.987 0.991 0.987
2 71523 0.965 0.975 0.975 0.971 0.970 0.975 0.975
3 37110 0.989 0.990 0.988 0.987 0.988 0.987 0.984
4 31432 0.995 0.997 0.995 0.992 0.995 0.997 0.994
5 42731 0.991 0.988 0.982 0.981 0.981 0.993 0.981
6 6233 0.986 0.988 0.981 0.978 0.973 0.990 0.982
7 6245 0.951 0.957 0.935 0.926 0.929 0.951 0.941
8 7701 0.923 0.935 0.912 0.908 0.902 0.920 0.904
9 6235 0.966 0.971 0.962 0.948 0.945 0.972 0.962
10 78374 0.972 0.971 0.979 0.965 0.971 0.975 0.957
11 78331 0.984 0.985 0.985 0.971 0.973 0.989 0.978
Mean 0.973 0.977 0.971 0.965 0.965 0.976 0.967
https://doi.org/10.1371/journal.pone.0189538.t010
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discovery of novel drugs, where 2 (Ada_Bag and Ada_RF) out of 6 AdaBoost classifiers
(Table 10 –DS1) outperformed the existing best classifier (LSVM).
Furthermore, Table 11 (with DS2) illustrates that 4 (Ada_Bag, Ada_J48, Ada_RF and
Ada_RT) out of 6 AdaBoost classifiers outperformed the LSVM classifier. Table 12 (with DS3)
illustrates that there was 1 (Ada_Bag) out of 6 AdaBoost classifiers that surpassed the LSVM
classifier for AUC measurements.
From the results illustrated in Tables 4–12, for all three measures (sensitivity, specificity
and AUC), it can be seen that in most cases the AdaBoost ensemble classifiers provided better
outcomes when compared with LSVM; these ensemble methods built a sequence of base mod-
els where each model was constructed based on the performance of the previous model on the
training set. In other words, by suitably combining the results of a set of base classifiers, the
performance obtained was better than that of any base classifier.
This study used a cut-off value of 0.05 for the significance level (p-value). The p-value was
considered significant and capable of providing an overall ranking if p<0.05 and the critical
value for chi-square χ2 at p = 0.05 for 6 degrees of freedom was 12.59. The degrees of freedom
are equal to the total number of algorithms minus 1. In this study, there were 7 algorithms
applied (LSVM + six AdaBoost ensemble classifiers), leading to 6 degrees of freedom. The
results of Kendall’s W tests are presented in Tables 13–15 (below).
Table 12. AUC measure for the prediction of new bioactive molecules with DS3 (heterogeneous).
Class
of DS3
Activity
Index
LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
1 09249 0.989 0.984 0.988 0.983 0.982 0.989 0.984
2 12455 0.973 0.978 0.967 0.965 0.967 0.978 0.967
3 12464 0.953 0.949 0.954 0.951 0.953 0.954 0.945
4 31281 0.986 0.977 0.967 0.934 0.943 0.958 0.948
5 43210 0.973 0.977 0.965 0.971 0.969 0.976 0.966
6 71522 0.954 0.958 0.957 0.954 0.946 0.954 0.938
7 75721 0.989 0.987 0.979 0.971 0.974 0.984 0.977
8 78331 0.914 0.925 0.894 0.899 0.911 0.919 0.914
9 78348 0.945 0.954 0.937 0.948 0.941 0.944 0.930
10 78351 0.960 0.968 0.957 0.957 0.960 0.968 0.960
Mean 0.963 0.965 0.956 0.953 0.954 0.962 0.953
https://doi.org/10.1371/journal.pone.0189538.t012
Table 11. AUC measure for the prediction of new bioactive molecules with DS2 (homogeneous).
Class
of DS2
Activity
Index
LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
1 07707 0.983 0.980 0.983 0.978 0.978 0.985 0.983
2 07708 0.984 0.983 0.981 0.987 0.974 0.993 0.974
3 31420 0.996 0.996 0.997 0.995 0.997 0.997 0.997
4 42710 0.991 0.986 0.986 0.991 0.986 0.982 0.995
5 64100 0.981 0.984 0.984 0.985 0.983 0.986 0.984
6 64200 0.864 0.884 0.855 0.903 0.877 0.859 0.877
7 64220 0.998 0.998 0.996 0.997 0.997 0.997 0.998
8 64300 0.984 0.976 0.976 0.988 0.984 0.984 0.988
9 65000 0.999 0.998 0.998 0.997 0.997 0.998 0.999
10 75755 0.998 0.998 0.997 0.998 0.998 0.998 0.997
Mean 0.977 0.978 0.975 0.982 0.977 0.978 0.979
https://doi.org/10.1371/journal.pone.0189538.t011
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Table 13. Rankings of existing best performing classifier (LSVM) and AdaBoost ensemble classifiers, based on Kendall’s W test results using the MDDR dataset by
sensitivity measure.
Datasets W χ 2 p Ranks
DS1 0.506 33.387 0.000 Technique LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
Mean Ranks 4.45 5.91 4.18 2.36 2.68 5.86 2.55
DS2 0.086 5.176 0.521 Technique LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
Mean Ranks 4.4 4.1 3.1 4.1 3.25 4.4 4.65
DS3 0.397 23.827 0.001 Technique LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
Mean Ranks 5.10 5.70 3.70 2.55 2.85 5.35 2.75
https://doi.org/10.1371/journal.pone.0189538.t013
Table 14. Rankings of existing best performing classifier (LSVM) and AdaBoost ensemble classifiers, based on Kendall’s W test results using the MDDR dataset by
specificity measure.
Datasets W χ2 p Ranks
DS1 0.413 27.287 0.000 Technique LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
Mean Ranks 4.64 5.45 4.45 2.27 2.73 5.36 3.09
DS2 0.043 2.562 0.862 Technique LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
Mean Ranks 3.70 4.30 3.90 3.80 3.70 3.95 4.65
DS3 0.432 25.895 0.000 Technique LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
Mean Ranks 4.05 5.65 4.50 2.55 2.55 5.70 3.00
https://doi.org/10.1371/journal.pone.0189538.t014
Table 15. Rankings of existing best performing classifier (LSVM) and AdaBoost ensemble classifiers, based on Kendall’s W test results using the MDDR dataset by
AUC measure.
Datasets W χ 2 p Ranks
DS1 0.600 39.573 0.000 Technique LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
Mean Ranks 4.50 5.91 4.41 2.18 2.27 6.00 2.73
DS2 0.122 7.293 0.295 Technique LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
Mean Ranks 4.35 3.90 2.95 4.30 3.15 4.55 4.80
DS3 0.486 29.133 0.000 Technique LSVM Ada_Bag Ada_Jrip Ada_J48 Ada_PART Ada_RF Ada_RT
Mean Ranks 5.25 5.85 3.50 2.55 2.75 5.50 2.60
https://doi.org/10.1371/journal.pone.0189538.t015
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The analysis in Table 13 shows that Kendall’s coefficients (for DS1 and DS3 using the sensi-
tivity measure) were significant (p<0.05, χ 2>12.59) and that the performance of Ada_Bag sig-
nificantly outperformed all of the other methods. The overall rankings for DS1 were
Ada_Bag>Ada_RF> LSVM >Ada_Jrip and Ada_PART>Ada_RT> Ada_J48. For DS3, they
were Ada_Bag>Ada_RF> LSVM>Ada_Jrip>Ada_PART>Ada_RT> Ada_J48.
Table 14 illustrates that Kendall’s coefficients (also for DS1 and DS3 using the specificity
measure) were significant (p<0.05, χ 2> 12.59) and that the performance of Ada_Bag in DS1
and Ada_RF in DS3 significantly outperformed all of the other methods. The overall rankings
for DS1 were Ada_Bag>Ada_RF> LSVM>Ada_Jrip>Ada_RT>Ada_PART> Ada_J48. For
DS3 the rankings were Ada_RF>Ada_Bag>Ada_Jrip> LSVM >Ada_RT> Ada_J48
>Ada_PART.
Table 15 illustrates that Kendall’s coefficients (also for DS1 and DS3 using the AUC mea-
sure) were significant (p<0.05, χ 2> 12.59) and that the performance of Ada_RF and Ada_Bag
considerably surpassed all of the other methods. The overall rankings for DS1 were Ada_RF>
Ada_Bag> LSVM >Ada_Jrip>Ada_RT>Ada_PART> Ada_J48. For DS3 they were
Ada_Bag>Ada_RF> LSVM >Ada_Jrip>Ada_PART>Ada_RT> Ada_J48.
In contrast, it can be seen in Tables 13–15 that the results for DS2 using all measures
(sensitivity, specificity and AUC) were not significant (p> 0.05, χ 2 < 12.59) because the per-
formance of all classifiers in DS2, even though good, were very similar to each other. As such,
the differences were not significant.
Fig 1 (below) illustrates that the highest accuracy was obtained by Ada_PART 96.72% in
DS1, Ada_J48 with 98.11% in DS2, and Ada_Bag with 94.54% in DS3. Thus, from the results
in Fig 1, we can also conclude that AdaBoost classifiers were able to handle all the datasets.
Most importantly, the results for DS3 (Fig 1) show that using Ada_Bag as the AdaBoost
classifier improved the effectiveness of the prediction of new bioactive molecules in highly
Fig 1. Accuracy rates for the prediction of new bioactive molecules with MDDR (DS1, DS2 and DS3).
https://doi.org/10.1371/journal.pone.0189538.g001
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diverse data when compared to using the existing best classification method (LSVM). The
results of DS3 show an accuracy of 94.54% compared to 93.73% for LSVM.
In comparison, our proposed methods outperform the method adopted by Liu et al. [44], of
which the Liu et al. 2016 method supersedes four other works, as illustrated in their report.
Conclusions
In this paper, we have presented various machine learning and ensemble methods that were
applied to three MDDR benchmark datasets. The results of the experiments illustrate that the
incorporation of the boosting algorithm (AdaboostM1), in conjunction with Bagging (Ada_-
Bag) and Random Forest (Ada_RF) as the nominal classifiers into the in silico discovery of
drugs, provides a significant improvement with regard to highly diverse datasets. In future
research, other ensemble methods will be examined to see if they improve the effectiveness of
the prediction of new bioactive molecules.
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